Zentalis Pharmaceuticals
ZNTL
#9381
Rank
โ‚น12.38 B
Marketcap
โ‚น126.02
Share price
0.00%
Change (1 day)
4.97%
Change (1 year)

Earnings for Zentalis Pharmaceuticals (ZNTL)

Earnings in 2026 (TTM): -โ‚น12.79 Billion

According to Zentalis Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น12.66 Billion, an increase over its 2024 earnings that were of -โ‚น15.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zentalis Pharmaceuticals from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น12.79 Billion1.01%
2025 -โ‚น12.66 Billion-17.55%
2024 -โ‚น15.36 Billion-40.16%
2023 -โ‚น25.66 Billion25.12%
2022 -โ‚น20.51 Billion34.48%
2021 -โ‚น15.25 Billion39.33%
2020 -โ‚น10.95 Billion154.74%
2019 -โ‚น4.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.75 Billion 14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.69 Billion-86.92%๐Ÿ‡บ๐Ÿ‡ธ USA